Feb 12, 2020
Digi-Tech Pharma & Artificial Intelligence | 2-Day Conference: London, UK - May 13th-14th, 2020
Jan 20, 2020
Contract Research Organization (CRO) Market Outlook to 2024 - Increased Technology Adoption in the Form of eClinical Solutions & Innovative Trial Designs Expected to Transform the CRO Landscape
Jan 09, 2020
Presage Receives FDA Clearance of First IND Application for Trial to Evaluate Investigational Oncology Agents with CIVO(TM) Technology
Jan 07, 2020
AlzeCure Pharma Conducts Strategic Inlicensing of Clinical Phase Drug Candidate for Neuropathic Pain
Jan 06, 2020
VC Funding for AI in Drug Development & Clinical Trials Hits $5.2B
Jan 06, 2020
IDEAYA Biosciences to Present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020
Jan 06, 2020
CStone Pharmaceuticals and Blueprint Medicines Initiate Phase 1b/2 Clinical Trial of Fisogatinib in Combination with CS1001 for Patients with Hepatocellular Carcinoma
Dec 20, 2019
AlzeCure Initiates Clinical Trial With ACD856
Nov 12, 2019
Lantern Phrama Selects REPROCELL Inc., for Drug Screening and Biomarker Discovery Services
Nov 11, 2019
MabPlex Congratulates Encure Biopharma with FDA IND Clearance of YH001 for the Treatment of a Broad Range of Cancers
Nov 06, 2019
Former Vice President and Global Head of Quantitative Clinical Pharmacology at AstraZeneca Joins NDA Partners
Nov 05, 2019
Provention Bio Reports Third Quarter 2019 Financial Results
Nov 05, 2019
Curis Reports Third Quarter 2019 Financial Results
Nov 04, 2019
Sierra Oncology Reports Third Quarter 2019 Results
Oct 26, 2019
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)
Oct 15, 2019
Therapix Biosciences Announces Positive Data From Recent Pre-clinical Study for New Drug Candidate THX-210
Sep 18, 2019
Former Executive Director of Preclinical Safety at Novartis, Klaus Peter Hoffmann, MD, PhD, Joins NDA Partners as Expert
Sep 17, 2019
FDA Awards AnaBios Grant to Further Develop Preclinical Assay Using Human Primary Cardiomyocytes
Sep 04, 2019
RegeneRx Modifies September Conference Schedule
Aug 29, 2019
Asia Pacific Drug Development Markets, 2019-2026 - Market is Expected to Reach USD 62.46 Billion